بِسْمِ اللَّهِ الرَّحْمَٰنِ الرَّحِيمِ
7 Jumada al-Akhirah 1448 AH
Fajr: 04:36 Dhuhr: 11:58 Asr: 15:12 Maghrib: 18:02 Isha: 19:11
☪
فَاسْأَلُوا أَهْلَ الذِّكْرِ
Islamic Education & Youth

Professor Mariam Jamal-Hanjani Appointed Chief Clinician at Cancer Research UK

By: Asep Darmawan • Nov 17, 2026 • 3 min read

Professor Mariam Jamal-Hanjani has been officially appointed as the new Chief Clinician at Cancer Research UK, taking on a pivotal leading role in shaping the esteemed charity’s clinical research strategy and spearheading ongoing efforts to significantly improve cancer treatment paradigms.

In her new capacity, Professor Jamal-Hanjani will guide the organisation’s clinical research agenda, leveraging her extensive background in oncology to drive forward innovations that aim to transform patient care. Her appointment marks a notable transition in leadership for the charity, placing one of the field’s most respected minds at the forefront of its nationwide mission to beat cancer.

A Distinguished Background in Cancer Genomics

Cancer Research UK Appoints Muslim Professor as Chief Clinician Cancer Research UK Appoints Muslim Professor as Chief Clinician - ilmfeed

Alongside her new responsibilities with Cancer Research UK, Professor Jamal-Hanjani serves as a Professor of Cancer Genomics and Metastasis at University College London (UCL). She is widely recognised as an international authority specialising in the intricate ways cancer evolves, spreads throughout the body, and develops resistance to conventional treatments.

Her pioneering academic and clinical work includes leading major, high-profile studies investigating lung cancer. Through this extensive research, she has helped the global scientific community gain a much deeper understanding of how tumours change over time and why certain forms of cancer ultimately become significantly harder to treat. This body of work is considered vital for the future of oncology, as it lays the theoretical and practical groundwork required to pave the way for more highly targeted treatments, personalised medicine approaches, and ultimately better survival outcomes for patients facing a cancer diagnosis.

Leadership and Vision for the Future

The appointment has drawn widespread praise from senior figures within the scientific and charitable sectors. Michelle Mitchell, the Chief Executive of Cancer Research UK, welcomed Professor Jamal-Hanjani to the role by highlighting her exceptional track record of scientific leadership and her dedication to translational research.

Cancer Research UK Appoints Muslim Professor as Chief Clinician Cancer Research UK Appoints Muslim Professor as Chief Clinician - ilmfeed

"Mariam brings to Cancer Research UK deep experience of leading high-performing research teams that are delivering radical new insights into how cancer changes as it grows, spreads, resists treatment and sometimes returns," Michelle Mitchell said, praising the profound impact of her work.

Reflecting on her new position and the responsibilities ahead, Professor Jamal-Hanjani expressed both enthusiasm and a strong sense of duty toward the charity’s overarching goals.

"Cancer Research UK has an extraordinary track record of turning scientific discovery into real-world benefit for patients, and the chance to help shape that mission is something I feel deeply privileged to take on," Professor Jamal-Hanjani stated.

She further emphasised her ambition to accelerate the translation of laboratory breakthroughs into practical clinical outcomes that can directly benefit individuals undergoing cancer care. In discussing the implementation of these advancements, she highlighted the National Health Service (NHS) as a major, invaluable asset capable of efficiently connecting pioneering scientific discoveries with the patients who need them most.

Cancer Research UK Appoints Muslim Professor as Chief Clinician Cancer Research UK Appoints Muslim Professor as Chief Clinician - ilmfeed

Building on a Legacy of Excellence

Professor Jamal-Hanjani officially stepped into her new role in October 2026. She succeeds Professor Charles Swanton, another prominent figure in the field of cancer research, who held the position of Chief Clinician since 2017 and left a lasting legacy of scientific advancement during his tenure.

As Professor Jamal-Hanjani assumes her duties, Cancer Research UK continues to look toward a future defined by cutting-edge genomics, precision medicine, and an unwavering commitment to improving the lives of individuals affected by cancer across the nation and beyond.

☪
Author / Editorial Team:

Asep Darmawan